Method for the production of biologically active polypeptides in a mammal's
AssigneePharming B.V.
InventorsJuha-Matti Hyttinen, Veli-Pekka Korhonen, Juhani Janne
Life of this patent
Estimating the term…
Abstract
A process is disclosed for the production of a protein or polypeptide in the milk of a transgenic non-human mammal where the protein or polypeptide is produced as fusion protein with another protein. The fusion protein can then be cleaved to release the protein or polypeptide. This method would reduce or prevent the formation of side effects associated with ectopic expression or leakage of the protein or polypeptide. Such a fusion protein is .beta.-lactoglobulin-EPO, where biologically active EPO is released upon cleavage of the fusion protein.
Claims9
A process for the production of erythropoietin in milk of a transgenic non-human mammal said process comprising the steps of:
- a) obtaining a mammary gland specific expression system comprising in operable linkage:
- 1) expression regulatory elements from a milk protein gene or a mammary tumor virus,
- 2) a DNA sequence encoding a signal sequence,
- 3) a DNA sequence encoding a fragment of a non-EPO protein, where the fragment is sufficient to reduce or prevent the formation of side effects associated with ectopic expression or leakage of erythropoietin, or a DNA sequence encoding a non-EPO protein, wherein the protein reduces or prevents the formation of side effects associated with ectopic expression or leakage of erythropoietin, and a
- 4) a DNA sequence encoding erythropoietin, whereby elements 3) and 4) are linked in frame forming a fusion protein,
- b) producing a transgenic non-human mammal comprising introducing the expression system of step a) into a non-human mammalian zygote or embryo, and maturing said zygote or embryo into a transgenic non-human mammal,
- c) expressing said fusion protein such that the fusion protein is secreted into the milk of said mammal,
- d) collecting said milk from the mammal or a female descendant of said mammal,
- e) isolating said recombinant fusion protein from said milk,
- f) releasing erythropoietin from said fusion protein, and
- g) purifying said erythropoietin.
A mammary gland specific expression system comprising in operable linkage:
- a) expression regulatory elements from a milk protein gene or a mammary tumor virus,
- b) a DNA sequence encoding a signal sequence,
- c) a DNA sequence encoding a fragment of a non-EPO protein, where the fragment is sufficient to reduce or prevent the formation of side effects associated with ectopic expression or leakage of erythropoietin, or a DNA sequence encoding a non-EPO protein, wherein the protein reduces or prevents the formation of side effects associated with ectopic expression or leakage of erythropoietin, and a
- d) a DNA sequence encoding erythropoietin, whereby elements 3) and 4) are linked in frame forming a fusion protein.
Dependencies are inferred from the claim text.